Sub: Recommendation of Dividend at the Board meeting held on May 30, 2025 Ref: Regulation 43 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 12.6 pts less than Nifty Microcap 250 and 12.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Directors of Coral Laboratories Ltd, at its meeting held on May 30, 2025, recommended a final dividend of 15%, i.e., ₹1.50 per equity share, on shares with a face value of ₹10 each, for the financial year 2024-25. This dividend is subject to the approval of shareholders at the upcoming Annual General Meeting. The disclosure is being made under Regulation 43 of SEBI's Listing Obligations and Disclosure Requirements, 2015. Once approved, the dividend will be paid to eligible shareholders based on the record date to be announced later.
A final dividend of ₹1.50 per share is a modest reward for shareholders and signals continued profitability, though the actual yield depends on the prevailing share price. Investors should watch for the record date announcement once the AGM date is fixed.